519 results
First clinical evidence from a new transcatheter solution utilizing cross-caval anchoring for untreatable TR
16 May 2024 – From EuroPCR 2024
Join Philipp Lurz and Rodrigo Estevez Loureiro as they discuss with Marta Sitges a groundbreaking treatment for tricuspid regurgitation involving the implantation of heterotopic prostheses. They emphasize the harmful effects of backward failure, describe the innovative cross-caval approach, and introduce the Trillium™ and Unica™ devices. This...
Interventions for valvular disease: Highlights of EuroPCR 2024
16 May 2024 – From EuroPCR 2024
Christopher Cook hosts Nicolas Dumonteil and Bernard Prendergast as they share EuroPCR 2024 insights on valve disease interventions. Nicolas Dumonteil highlights record-breaking abstracts and cases, demonstrating expertise in TAVI, mitral, and tricuspid procedures. Bernard Prendergast emphasizes LIVE cases, especially in complex TAVI scenarios, reflecting everyday practice. Both stress...
Rapid learning curve to TTVR with the Cardiovalve device
15 May 2024 – From EuroPCR 2024
Explore the discussion between Rodrigo Estevez Loureiro and Georg Nickenig on treating tricuspid regurgitation with the innovative Cardiovalve replacement therapy. Learn about the unique features and properties of this low-profile valve with a dual frame, and hear Estevez Loureiro share his firsthand experience using the TTVR...
Innovations in transcatheter valve interventions: moving the flow in the right direction
13 May 2024 – From EuroPCR 2024
Prediction of mortality and heart failure hospitalization after transcatheter tricuspid valve interventions: Validation of TRISCORE
25 Apr 2024
This study highlights the TRISCORE's role in assessing risk for patients undergoing TTVI. Despite limitations, TRISCORE effectively identifies high-risk patients, aiding decision-making in a complex landscape of valvular heart disease management.
Reviewer
Applying the TRILUMINATE eligibility criteria to real-world patients receiving tricuspid valve transcatheter edge-to-edge repair
19 Mar 2024
This study, based on the trial inclusion and exclusion criteria, aimed to compare outcomes in a contemporary “real-world” T-TEER cohort stratified by TRILUMINATE eligibility or ineligibility.
Reviewer
Reviewer
Uncertainties in transcatheter tricuspid interventions
Follow Karl-Philipp Rommel as he shares insights on physiology relevant to diagnosing and treating TR-related right heart failure.
In this video, you will:
- appreciate the challenges in patient assessment
- understand the need for adjunctive treatment targets
- acknowledge challenges in multivalvular disease
- Disease stages: criteria of futility and optimal response
- RV...
Hemodynamic implications of TTVI on right heart function
Follow Karl-Philipp Rommel as he shares insights on physiology relevant to diagnosing and treating TR-related right heart failure.
In this video you will learn:
- the theoretical implications of TR reduction for RV performance
- the clinical implications of TR reduction for biventricular performance
Implications of TTVI
Previous episode
Prognosis after transcatheter tricuspid interventions
Follow Karl-Philipp Rommel as he shares insights on physiology relevant to diagnosing and treating TR-related right heart failure.
In this video you will learn about:
- the data supporting prognostic implications of interventional TR reduction
- the prognostic value of hemodynamic factors
- the importance of central venous congestion
- Mortality and HF Hospitalization: Prognostic Benefit of Intervention...
Pathophysiology of right ventricular volume/pressure load
Follow Karl-Philipp Rommel as he shares insights on physiology relevant to diagnosing and treating TR-related right heart failure.
In this video you will learn:
- to recall the unique physiology of right ventricular function
- to understand the implications of RV pressure and volume load using the pressure-volume-loop framework
- to illustrate the...
